SCHEMBL21704231

SCHEMBL21704231

Cc1cc(C(F)(F)F)c2c(N)c(N)sc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
MAPT P10636 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CASP1 P29466 2/20 0.52
CASP7 P55210 2/20 0.52
NPC1 O15118 1/20 0.52
USP2 O75604 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
LMNA P02545 1/20 0.51
HPGD P15428 3/20 0.49
HSD17B10 Q99714 2/20 0.49
KDM4E B2RXH2 3/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPK1 P28482 1/20 0.43
BRCA1 P38398 1/20 0.43
HBB P68871 1/20 0.43
LIMK1 P53667 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19000276 0.87 ALDH1A1 (0.52) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL21704070 0.81 ALDH1A1 (0.50) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL30968413 0.80 ALDH1A1 (0.64) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL4899387 0.80 ALDH1A1 (0.64) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL23009510 0.78 LMNA (0.47) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL20731027 0.78 KDM4E (0.66) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL4898042 0.75 KDM4E (0.72) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL20731019 0.74 KDM4E (0.43) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL23938077 0.74 HSD17B10 (0.45) ALDH1A1MAPTSMN1; SMN2CASP1CASP7
SCHEMBL20732102 0.74 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033707-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2020-02-13 WO disclosed